Madrigal Pharmaceuticals Inc Share Price - MDGL | ADVFN Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). MDGL - Madrigal Pharmaceuticals Inc Share Price Profile Summary. Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). MDGL - Madrigal Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time MDGL - Madrigal Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.
The latest Madrigal Pharmaceuticals Inc USD0.00010 share price. View recent trades and share price information for Madrigal Pharmaceuticals Inc
MDGL | Complete Madrigal Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. MDGL Stock Price, Forecast & News (Madrigal Pharmaceuticals)
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular,
View the latest Madrigal Pharmaceuticals Inc. (MDGL) stock price, news, historical charts, analyst ratings and financial information from WSJ.
